SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2000 |
PE ASSETS | 19.0B USD |
Size | Mega |
Type | Sector Focused |
Accel-KKR is a private equity firm that seeks control and growth-oriented investments in middle-market technology companies. The Firm targets investments in public and private companies with revenues ranging from $15 to $150 million. Accel-KKR pursues transactions across multiple segments of the technology industry, including software, hardware and internet technologies, and IT enabled services. Accel-KKR's first fund was created in 2000 by Accel Partners and Kohlberg Kravis Roberts & Co. to invest in technology assets and businesses that were outside of each firm's core focus. Accel-KKR is based in Menlo Park, California.
DEAL STATS | # |
---|---|
Overall | 112 of 117 |
Sector (Software) | 50 of 52 |
Type (Growth Capital) | 51 of 53 |
State (Connecticut) | 2 of 2 |
Country (United States) | 78 of 81 |
Year (2023) | 4 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-07-17 |
FM:Systems
Raleigh, North Carolina, United States FM:Systems is a provider of Integrated Workplace Management Systems (IWMS) and Computer-Aided Facility Management (CAFM) software. FM:Systems’ over 300 blue-chip customer base spans six continents and a diverse range of industries, including healthcare, higher education, technology, manufacturing, retail, banking and the public sector. FM:Systems is headquartered in Raleigh, North Carolina, and conducts business throughout the Americas, Africa, Europe and Asia Pacific. |
Sell | $455M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-11-08 |
IntegriChain
Philadelphia, Pennsylvania, United States IntegriChain helps pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. The company delivers Pharma's only data-driven commercialization platform from strategy to operational execution. Its focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain was formed in 2007 and is based in Philadelphia, Pennsylvania. |
Sell | - |